Author Correction: Massively parallel phenotyping of coding variants in cancer with Perturb-seq

Oana Ursu^#^{1

2}, James T Neal^#¹, Emily Shea^{1

3}, Pratiksha I Thakore^{1

2}, Livnat Jerby-Arnon^{1

4

5}, Lan Nguyen¹, Danielle Dionne¹, Celeste Diaz^{1

6}, Julia Bauman^{1

5}, Mariam Mounir Mosaad¹, Christian Fagre¹, April Lo⁷, Maria McSharry⁷, Andrew O Giacomelli^{1

8

9}, Seav Huong Ly^{1

8

10}, Orit Rozenblatt-Rosen^{1

2}, William C Hahn^{1

8

11}, Andrew J Aguirre^{1

8

11}, Alice H Berger⁷, Aviv Regev^{12

13

14

15}, Jesse S Boehm¹⁶

Affiliations

¹ Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Genentech, South San Francisco, CA, USA.
³ Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Chan Zuckerberg Biohub, San Francisco, CA, USA.
⁵ Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
⁶ Department of Cancer Biology, Stanford University School of Medicine, Stanford, CA, USA.
⁷ Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁸ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁹ Princess Margaret Cancer Centre, Toronto, ON, Canada.
¹⁰ Duke-NUS Medical School, Singapore, Singapore.
¹¹ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
¹² Broad Institute of Harvard and MIT, Cambridge, MA, USA. aviv.regev.sc@gmail.com.
¹³ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. aviv.regev.sc@gmail.com.
¹⁴ Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. aviv.regev.sc@gmail.com.
¹⁵ Genentech, South San Francisco, CA, USA. aviv.regev.sc@gmail.com.
¹⁶ Broad Institute of Harvard and MIT, Cambridge, MA, USA. boehm@broadinstitute.org.

^# Contributed equally.

Published Erratum

Oana Ursu et al. Nat Biotechnol. 2022 Nov.

. 2022 Nov;40(11):1691.

doi: 10.1038/s41587-022-01495-9.

¹ Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Genentech, South San Francisco, CA, USA.
³ Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Chan Zuckerberg Biohub, San Francisco, CA, USA.
⁵ Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
⁶ Department of Cancer Biology, Stanford University School of Medicine, Stanford, CA, USA.
⁷ Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁸ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁹ Princess Margaret Cancer Centre, Toronto, ON, Canada.
¹⁰ Duke-NUS Medical School, Singapore, Singapore.
¹¹ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
¹² Broad Institute of Harvard and MIT, Cambridge, MA, USA. aviv.regev.sc@gmail.com.
¹³ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. aviv.regev.sc@gmail.com.
¹⁴ Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. aviv.regev.sc@gmail.com.
¹⁵ Genentech, South San Francisco, CA, USA. aviv.regev.sc@gmail.com.
¹⁶ Broad Institute of Harvard and MIT, Cambridge, MA, USA. boehm@broadinstitute.org.

^# Contributed equally.

No abstract available

Erratum for

Massively parallel phenotyping of coding variants in cancer with Perturb-seq.
Ursu O, Neal JT, Shea E, Thakore PI, Jerby-Arnon L, Nguyen L, Dionne D, Diaz C, Bauman J, Mosaad MM, Fagre C, Lo A, McSharry M, Giacomelli AO, Ly SH, Rozenblatt-Rosen O, Hahn WC, Aguirre AJ, Berger AH, Regev A, Boehm JS. Ursu O, et al. Nat Biotechnol. 2022 Jun;40(6):896-905. doi: 10.1038/s41587-021-01160-7. Epub 2022 Jan 20. Nat Biotechnol. 2022. PMID: 35058622